Clinical Trial Update: A Dose Selection Trial of CKD-330 in Patients With Essential Hypertension [Phase 2]

View source ↗

Summary

A Phase 2 dose-selection trial of CKD-330 in adults with essential hypertension; the study is sponsored by Chong Kun Dang Pharmaceutical and its status is liste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• CKD-330

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Essential Hypertension | Phase 2 | Status: UNKNOWN